All Research Papers Published In Blood Advances

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy for patients with myelofibrosis.

Platelets pull: how thrombin drives contractility.

Perioperative management of antithrombotic therapy in patients with thrombotic antiphospholipid syndrome.

Apohemoglobin-haptoglobin complex is a therapeutic against vaso-occlusive crisis: scavenging of hemoglobin and heme.

Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM.

Adherence to ITP guidelines and adequate immunotherapy.

Halofuginone vs the elevated hepcidin hurdle.

Immunophenotyping challenges in the diagnosis of NK-LGLL.

Acalabrutinib monotherapy as a first-line treatment for CLL: 3 years follow-up of the real-world EPIC study.

Retinal imaging and supervised learning predict hospitalizations, kidney, and heart-lung damage in sickle cell disease.